Pharmacogenetic Testing for Medication Management.
NCT02559193 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-08-01
Summary
The Study is a single-arm prospective trial of patients receiving at least one medication with a known association between genetics and drug metabolism. All patients will undergo genetic testing as determined by their treating physician. The specific genes tested will, in general, be based upon the drugs the patients are taking or those that the patient's treating physician is considering as potential substitutes for current medications.
Conditions
- Medication Management
Interventions
- OTHER
-
Observational study, data collection only trial.
Data collection only trial design.
Sponsors & Collaborators
-
First Vitals LLC
lead INDUSTRY
Principal Investigators
-
Ernie Lee, CHRS · First Vitals LLC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2018-05-31
- Completion
- 2018-05-31
More Related Trials
-
Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes
NCT01274065 ·Status: COMPLETED
-
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
NCT02095769 ·Status: UNKNOWN
-
Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability
NCT02568618 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
NCT05091879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Study of Advanced Data Analytics in Genetic Conditions
NCT05657405 ·Status: RECRUITING
-
Pharmacogenetic Testing and Chronic Pain
NCT05259865 ·Status: SUSPENDED
-
Research for Individualized Therapeutics in Rare Genetic Disease
NCT05236595 ·Status: ENROLLING_BY_INVITATION
-
Pharmacogenetic Testing in Primary Care
NCT01600846 ·Status: COMPLETED
-
Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects
NCT03748355 ·Status: COMPLETED ·Phase: NA
-
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
NCT03468309 ·Status: COMPLETED
-
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
NCT02487888 ·Status: UNKNOWN ·Phase: NA
-
Pediatric Patients With Metabolic or Other Genetic Disorders
NCT02769949 ·Status: COMPLETED
-
Pharmacogenomic Profiling of Pediatric Patients
NCT02770339 ·Status: COMPLETED
-
Pharmacogenomics Registry to Assess Clinical Utility
NCT02374840 ·Status: UNKNOWN
-
Clinical Integration of Genetic Risk Assessment in Family Medicine
NCT00339794 ·Status: COMPLETED
-
Pharmacogenomics of Antidepressant Response in Children and Adolescents
NCT00516932 ·Status: COMPLETED
-
Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum
NCT04889014 ·Status: COMPLETED ·Phase: NA
-
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825 ·Status: RECRUITING
-
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
NCT02485795 ·Status: UNKNOWN
-
Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
NCT01375543 ·Status: COMPLETED
-
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
NCT03829176 ·Status: COMPLETED ·Phase: NA
-
Studies of Children With Metabolic and Other Genetic Disorders
NCT00025870 ·Status: COMPLETED
-
Zoektocht Naar Erfelijke MetaBole Aandoening (Dutch)/ Solve The Unsolved (English)
NCT06200142 ·Status: COMPLETED ·Phase: NA
-
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
NCT00597090 ·Status: COMPLETED
-
Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana
NCT04083261 ·Status: COMPLETED